Replies to post #41060 on Ariad Pharmaceuticals Inc fka ARIA

[vidpok45]

I agree. Ariad is a great buyout candidate now but with Monday night's presentation there would now have to be a substantial premium because of the real possibility of ponatinib being a 2nd line drug utilizing a 30 or 15mg dose. I'm thinking mid teens as a buyout price now.

[girlfriend]

Good luck!!